Collaboration with pharmacy services in a family practice for the medically underserved

Pharmacy Practice

Volumn 7, Issue 4, 2009, Pages 248-253

  Enfinger, Fallon ^a   Campbell, Kendall ^b   Taylor, James R ^c  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Ambulatory care; Homeless persons; Medication therapy management; Pharmacists; Poverty; United States

Indexed keywords

HEMOGLOBIN A1C;

AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; DIABETES MELLITUS; GENERAL PRACTICE; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; HYPERTENSION; PHARMACIST; PHARMACY; PRIMARY MEDICAL CARE;

EID: 73649121322     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552009000400009     Document Type: Article

References (16)

1. Petty D. Drugs and professional interactions: the modern day pharmacist. Heart. 2003;89(Suppl III):ii31-ii32.
2. Anaya JP, Rivera JO, Lawson K, Garcia J, Luna J, Ortiz M. Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health-Syst Pharm. 2008;65:1841-1845.
3. Cioffi ST, Caron MF, Kalus JS, Hill P, Buckley TE. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother. 2004;38:771-775.
4. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-184.
5. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-159.
6. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality Assessment of a Collaborative Approach for Decreasing Drug-Related Morbidity and Achieving Therapeutic Goals. Arch Intern Med. 2003;163:1813-1820.
7. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828-1832.
8. Knapp KK, Okamoto MP, Black BL. ASHP survey of ambulatory care pharmacy practice in health systems - 2004. Am J Health-Syst Pharm. 2005;62:274-284.
9. Morello CM, Zadvorny EB, Cording MA, Suemoto RT, Skog J, Harari A. Development and clinical outcomes of pharmacist-managed diabetes care clinics. Am J Health-Syst Pharm. 2006;63:1325-1231.
10. Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health-Syst Pharm. 2008;65:145-149.
11. Ragucci KR, Fermo JD, Wessell AM, Chumney ECG. Effectiveness of Pharmacist-Administered Diabetes Mellitus Education and Management Services. Pharmacotherapy. 2005;25(12):1809-1816.
12. Till T, Voris J, Horst J. Assessment of clinical pharmacist management of lipid-lowering therapy in the primary care setting. J Manag Care Pharm 2003;9(3):269-273.
13. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care. 2009;32(Suppl 1):S13-61.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572
15. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among US adults with diabetes, 1999-2002. The National Health and Nutrition Examination Survey. Diabetes Care. 2006;29:531-537.
16. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999-2004. Hypertension. 2007;49:69-75.